Guild working on hep C cash flow problems

The Guild says it is continuing to work with stakeholders following the revelation that a large minority of pharmacies may not supply the expensive, newly-listed Hepatitis C drugs to patients for economic reasons.Last week the AJP reported on the results of a reader survey which found that 22% of respondents were not providing the drugs

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Australians urged to 'take charge' of their medicines
Next NDSS changes a mixed bag